For the quarter ending 2026-03-31, AWHL made $1,967K in revenue. $676K in net income. Net profit margin of 34.37%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 1,967 | 2,153* | 2,305 | 2,404 |
| Cost Of Goods And Services Sold | 896 | 613 | 922 | 870 |
| Total cost of revenue | 896 | 613* | 922 | 870 |
| Gross profit | 1,071 | 1,540* | 1,383 | 1,534 |
| Research and development | 1,226 | 714* | 739 | 704 |
| Sales and marketing | 543 | 943* | 683 | 679 |
| General and administrative | 1,505 | 2,713* | 1,540 | 1,961 |
| Total operating expenses | 3,274 | 4,369* | 2,962 | 3,344 |
| Loss from operations | -2,203 | -2,829* | -1,579 | -1,810 |
| Change in fair value of warrant liabilities | -3,110 | -1,793* | 4,309 | 624 |
| Change in fair value of convertible notes | - | -170* | - | 0 |
| Other income (expense), net | - | 624* | 1,009 | -219 |
| Loss upon issuance of convertible notes carried at fair value | - | 1,198* | - | 0 |
| Interest expense, net | -231 | -2* | -13 | -13 |
| Total other (expense) income, net | 2,879 | 1,387* | -3,313 | -856 |
| Net income (loss) before taxes | 676 | - | - | - |
| Net income (loss) | 676 | -1,443 | -4,892 | -2,666 |
| Basic EPS | 0.02 | -0.048 | -0.13 | -0.07 |
| Diluted EPS | -0.05 | -0.048 | -0.13 | -0.07 |
| Basic Average Shares | 43,492,279 | 30,355,878 | 36,388,370 | 35,564,032 |
| Diluted Average Shares | 45,773,842 | 30,355,878 | 36,388,370 | 35,564,032 |
Aspira Women's Health Inc. (AWHL)
Aspira Women's Health Inc. (AWHL)